Back
ESC Premium Access

Non-LDL in CV risk management & guidelines: What are the opportunities?

Session: Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides
Topic: Secondary Prevention
Speaker: Professor K. Ray (London, GB)
Organised by PACE-CME, supported by Amarin in the form of an educational grant
Event: ESC Congress 2020

Congress Presentation

0

About the speaker

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
59 presentations
4 followers

4 more presentations in this session

Introduction.

Speaker: Professor P. Libby (Boston, US)

Access
Video
0
Thumbnail

The residual risk challenge in CVD: How important are triglycerides?

Speaker: Professor U. Landmesser (Berlin, DE)

Access
Video
0
Thumbnail

Lessons from REDUCE-IT: How will the results impact practice?

Speaker: Professor D. Bhatt (New York City, US)

Access
Video
0
Thumbnail

Discussion.

Speaker: Professor P. Libby (Boston, US)

Access
Video
0
Thumbnail

Access the full session

Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides

Speakers: Professor K. Ray, Professor P. Libby, Professor U. Landmesser, Professor D. Bhatt, Professor P. Libby
Access
Video
0
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

Related content

Open Access

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - panel .

27 August 2021

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

ESC Premium Access

Triglycerides: the underestimated player.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk